Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Simsek (Ankara, Turkey), G. Bakici Sari (Ankara, Turkey), B. Akgündüz (Ankara, Turkey), V. Türksoy (Yozgat, Turkey), Y. Agaçkiran (Ankara, Turkey), N. Tezer (Ankara, Turkey), D. Özdemir (Ankara, Turkey). Essential trace element levels in IPF patients: a case control study. 728

Member's Comments

No comment yet.

Related content which might interest you: Special features of pulmonary tuberculosis among smokers: A case control study Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation Year: 2019 VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018 High « red cell distribution width » levels can predict  pulmonary embolism risk in multiple trauma patients: a case control study. Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017 Medication use in children with asthma: a case control study Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001 Smoking and pulmonary tuberculosis: a case control study Source: Eur Respir J 2005; 26: Suppl. 49, 190s Year: 2005 Measuring patient activation in an interstitial lung disease (ILD) population: an exploratory study Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Role of complement activation product C4d as apredictor biomarker in lung cancer diagnosis : case control study Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Phenotypic characterisation of early COPD: a prospective case–control study Source: ERJ Open Res, 6 (4) 00047-2020; 10.1183/23120541.00047-2020 Year: 2020 Patients‘ perception of their own influence on asthma (locus of control). Results from an observational study Source: Eur Respir J 2007; 30: Suppl. 51, 147s Year: 2007 A COPD patient case study Source: Annual Congress 2012 - NIV - Meeting the Experts: From state-of-the-art to new technologies Year: 2012 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Relationship between level of asthma control and stability: GOAL study Source: Eur Respir J 2006; 28: Suppl. 50, 318s Year: 2006 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Asthma control and management in Spain, a study of factors associated to asthma control (CHAS study) Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008 Difference in asthma control levels by assessment tools: Observational study Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Low agreement between current and long-term asthma control in children: The PACMAN cohort study Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009